Quantum Annealing Designs Nonhemolytic Antimicrobial Peptides in a Discrete Latent Space

Increasing the variety of antimicrobial peptides is crucial in meeting the global challenge of multi-drug-resistant bacterial pathogens. While several deep-learning-based peptide design pipelines are reported, they may not be optimal in data efficiency. High efficiency requires a well compressed latent space, where optimization is likely to fail due to numerous local minima. We present a multi-objective peptide design pipeline based on a discrete latent space and D-Wave quantum annealer with the aim of solving the local minima problem. To achieve multi-objective optimization, multiple peptide properties are encoded into a score using non-dominated sorting. Our pipeline is applied to design therapeutic peptides that are antimicrobial and non-hemolytic at the same time. From 200 000 peptides designed by our pipeline, four peptides proceeded to wet-lab validation. Three of them showed high anti-microbial activity, and two are non-hemolytic. Our results demonstrate how quantum-based optimizers can be taken advantage of in real-world medical studies.

Automated summary

Increasing the variety of antimicrobial peptides is crucial to tackle multi-drug-resistant bacterial pathogens. A multi-objective peptide design pipeline based on a discrete latent space and D-Wave quantum annealer was developed to solve the local minima problem. Four peptides designed by the pipeline were validated in wet-lab experiments, with three of them showing high antimicrobial activity and two being non-hemolytic.